Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway

Published:2020-01 Issue:1 Volume:75 Page:45-53
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Yang Xue-Juan,Liu Fang,Feng Na,Ding Xue-Song,Chen Yong,Zhu Shuang-Xi,Yang Ling-Chao,Feng Xiang-Fei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference22 articles.

1. The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis

2. Macrophage-Derived Foam Cells in Atherosclerosis: Lessons from Murine Models and Implications for Therapy

3. Protein Kinase Cθ Via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6C hi Cells Contributes to Atherosclerosis

4. Cholesterol Efflux Capacity

5. Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe −/− mice with hyperhomocysteinemia

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies;Frontiers in Pharmacology;2024-06-18

2. The place of berberine in the treatment of metabolic syndrome;Experimental and Clinical Gastroenterology;2024-03-15

3. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review;Journal of Translational Medicine;2024-03-01

4. Is the suppression of CD36 a promising way for atherosclerosis therapy?;Biochemical Pharmacology;2024-01

5. Bioactive plant molecules, sources, and mechanisms of action in the treatment of cardiovascular diseases;Pharmacognosy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3